Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
PACB - Pacific Biosciences of Californ
Market Cap 3.13B P/E - EPS this Y 15.70% Ern Qtrly Grth -
Income -306.74M Forward P/E -12.52 EPS next Y 19.60% 50D Avg Chg -5.00%
Sales 200.52M PEG 1.35 EPS past 5Y - 200D Avg Chg 17.00%
Dividend N/A Price/Book 4.88 EPS next 5Y -1.00% 52W High Chg -14.00%
Recommedations 2.40 Quick Ratio 7.06 Shares Outstanding 267.95M 52W Low Chg 162.00%
Insider Own 2.80% ROA -10.92% Shares Float 266.46M Beta 1.83
Inst Own 102.41% ROE -48.53% Shares Shorted/Prior 48.52M/45.57M Price 12.52
Gross Margin 29.02% Profit Margin -152.97% Avg. Volume 3,583,696 Target Price 6.08
Oper. Margin -142.14% Earnings Date Apr 30 Volume 6,211,175 Change -6.15%
Healthcare | Medical Devices | United States
About Pacific Biosciences of Californ

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Pacific Biosciences of Californ News
04/25/24 Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks
04/23/24 Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know
04/18/24 Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18%
04/17/24 PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
04/16/24 The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
04/16/24 PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
04/03/24 Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
03/27/24 Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
03/22/24 PacBio Grants Equity Incentive Award to New Employee
03/13/24 11 Oversold NASDAQ Stocks To Buy Right Now
03/13/24 PacBio's (PACB) New Panel to Aid Its Clinical Research Solution
03/12/24 PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
03/06/24 Director David Meline Acquires 40,000 Shares of Pacific Biosciences of California Inc (PACB)
02/27/24 12 Best Medical Stocks to Buy Under $10
04:05 PM PacBio to Present at Upcoming Investor Conferences
02/25/24 14 Best Beaten Down Stocks To Buy Right Now
02/22/24 13 Best Falling Stocks To Buy Right Now
02/16/24 PacBio (PACB) Q4 Earnings Beat, Adjusted Gross Margin Down
02/16/24 Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2023 Earnings Call Transcript
02/16/24 Q4 2023 Pacific Biosciences of California Inc Earnings Call
PACB Chatroom

User Image singlestocks4life Posted - 1 hour ago

$PACB handle of the cup finalizing in after hours..

User Image JasonLg Posted - 3 hours ago

$PACB MACD and RSI curling up

User Image JasonLg Posted - 3 hours ago

$PACB At the bottom of the channel 2 upper gaps to fill

User Image ZidaneMaradona Posted - 6 hours ago

$PACB dead money

User Image Magic8BallResponse Posted - 7 hours ago

$PACB How much is this down from the high?????

User Image SM07 Posted - 9 hours ago

$PACB The business opportunity has proved to be way less attractive than originally thought. Material price cuts only way forward to stimulate demand.

User Image JayBirdEvans Posted - 9 hours ago

$PACB Time to prove these bears wrong! Let’s Go!

User Image GDog77 Posted - 9 hours ago

$PACB Gotta LOVE Joe Blow Biden's sh*t market. Everything retail invested heavily into has gotten absolutely sh*t on...

User Image GDog77 Posted - 9 hours ago

$PACB what a waste product...best days are definitely behind this.

User Image 2019Bull2025 Posted - 10 hours ago

$PACB long to mid rsi chart for this one is in the buy zone

User Image v92 Posted - 10 hours ago

$PACB Buyout rumors should start soon, taking it to $5 before $ILMN acquires for $10.

User Image 2019Bull2025 Posted - 11 hours ago

$PACB inflation report showed a 1% rise over the expected 2.7% rise, That’s not gonna shake the market. if we would’ve gone to report over 3% then I would be stating the opposite

User Image KimAntony Posted - 12 hours ago

$PACB dropping back now and nearly back to last night's closing price.

User Image KimAntony Posted - 12 hours ago

$PACB if today is like yesterday then the whole market is going to tank as we get to 8:30 when the Personal/Income Spending for March comes out.

User Image MingLin Posted - 20 hours ago

$PACB Bullish case? Are you is dumb

User Image thinkofpurple Posted - 22 hours ago

$PACB I bough $28 worth of this POS today

User Image 2019Bull2025 Posted - 1 day ago

$PACB inflation report tomorrow it’s either going to be a win for small cap or a lose for a small cap

User Image Sbutle01 Posted - 1 day ago

$PACB I took an interest in this stock because Cathy Wood bought it for her genomic fund. My return is hilarious. I’m down 57% in like a month. I only bought $20 worth so I can lolz. I lost like $3k on this stock like 3 years ago.

User Image peterb030 Posted - 1 day ago

$PACB crazy day

User Image 2019Bull2025 Posted - 1 day ago

$PACB bye-bye Penny traders

User Image JayBirdEvans Posted - 1 day ago

$PACB Nice recovery. Glad I added that dip

User Image 2019Bull2025 Posted - 1 day ago

$PACB looking at some charts it looks like hedge funds have been selling equally and buying equally on both sides, little tilted on the selling side but not by much.

User Image Ty_Bryant2 Posted - 1 day ago

$PACB ⏳📈

User Image WallStreetBuyDip Posted - 1 day ago

This is the track record showing the results for Small + Mid cap stocks from ONLY buying when H% is low. All include timestamps + buy fills for everything. The result speaks for itself. Will next trade $OCGN + $PACB when H% is low for a reversal trade like I did for other small + mid caps. How do you trade in the market?

User Image WallStreetBuyDip Posted - 1 day ago

I compiled my past trades to show how I make my trades. Every time I set a buy, it's only when H% is low. Here's the track record for Small + Mid Caps (Part 2) Got timestamps + buy fills for everything. This shows the result of ONLY buying when H% is low The result speaks for itself. Next, I'll trade $OCGN + $PACB and more

User Image Bedtimereminder Posted - 1 day ago

$PACB yeah…end to end to the END

User Image Bedtimereminder Posted - 1 day ago

$BNGO $PACB go go bngo!

User Image scottpetet Posted - 1 day ago

$PACB So the future of genomic medicine doesn’t use long reads?? So USA doesn’t lead biotech?? No brainer…..

User Image ahmadlinus Posted - 1 day ago

$PACB market goes up, this goes down. Market goes down, it goes down😭will there be a breakthrough?

User Image pierresa78 Posted - 1 day ago

$PACB Hopefully this is bottom .. adding more on that dip

Analyst Ratings
JP Morgan Neutral Apr 22, 24
Goldman Sachs Neutral Apr 19, 24
Bernstein Outperform Apr 18, 24
Goldman Sachs Neutral Apr 18, 24
Scotiabank Sector Outperform Apr 18, 24
TD Cowen Buy Apr 17, 24
Barclays Equal-Weight Apr 10, 24
Goldman Sachs Buy Apr 10, 24
UBS Buy Feb 16, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Van Oene Mark See Remarks See Remarks Jan 09 Sell 7.773 31,012 241,056 910,171 01/10/24
Kim Susan G. See Remarks See Remarks Sep 29 Sell 8.437 19,257 162,471 306,085 09/29/23
Eidel Jeff See Remarks See Remarks Aug 17 Sell 10.597 25,936 274,844 444,666 08/18/23
Farmer Michele See Remarks See Remarks May 18 Sell 12.59 5,165 65,027 107,577 05/19/23
Kim Susan G. See Remarks See Remarks Feb 17 Sell 10.271 907 9,316 162,581 02/22/23
HENRY CHRISTIAN O See Remarks See Remarks Feb 17 Sell 10.271 1,530 15,715 642,021 02/22/23
Van Oene Mark See Remarks See Remarks Jan 10 Sell 9.534 26,722 254,768 640,808 01/11/23
Kim Susan G. See Remarks See Remarks Sep 29 Sell 5.614 12,968 72,802 163,488 10/03/22
MOHR MARSHALL Director Director Jun 10 Option 1.83 35,000 64,050 60,000 06/13/22
Farmer Michele See Remarks See Remarks May 18 Sell 5.547 3,573 19,819 60,354 05/20/22
ORDONEZ KATHY Director Director Feb 16 Sell 11.5 3,280 37,720 18,595 02/17/22
MOHR MARSHALL Director Director Jan 14 Option 3.57 25,000 89,250 25,000 01/19/22
Van Oene Mark Chief Operating Offi.. Chief Operating Officer Jan 11 Sell 14.23 41,480 590,260 293,520 01/13/22
Fromen Peter Chief Commercial Off.. Chief Commercial Officer Jan 11 Sell 14.3 19,720 281,996 140,280 01/13/22
Ericson William W. Director Director May 26 Option 6.21 37,500 232,875 37,500 05/26/21
Hunkapiller Michael Director Director Feb 26 Option 6.27 605,804 3,798,391 1,187,782 02/26/21
Hunkapiller Michael Director Director Feb 26 Sell 34.83 605,804 21,100,153 848,405 02/26/21
ORDONEZ KATHY Director Director Feb 18 Option 5.18 185,879 962,853 242,646 02/18/21
ORDONEZ KATHY Director Director Feb 18 Sell 48.35 220,771 10,674,278 21,875 02/18/21
LIVINGSTON RANDALL S Director Director Feb 17 Option 4.98 67,500 336,150 67,500 02/17/21
LIVINGSTON RANDALL S Director Director Feb 17 Sell 48.07 67,500 3,244,725 02/17/21
Botstein David Director Director Feb 17 Option 4.58 160,000 732,800 160,000 02/17/21
Botstein David Director Director Feb 17 Sell 49.85 160,000 7,976,000 02/17/21
Hunkapiller Michael Director Director Jan 27 Option 6.14 125,406 769,993 973,811 01/27/21
Hunkapiller Michael Director Director Jan 27 Sell 36.53 125,406 4,581,081 848,405 01/27/21
Hunkapiller Michael Director Director Jan 22 Option 4.21 574,594 2,419,041 999,262 01/22/21
Hunkapiller Michael Director Director Jan 22 Sell 37.87 624,404 23,646,179 848,405 01/22/21
Hunkapiller Michael Director Director Dec 23 Option 4.72 700,000 3,304,000 1,262,666 12/23/20
Hunkapiller Michael Director Director Dec 23 Sell 23.88 700,000 16,716,000 898,215 12/23/20